Sun Pharmaceutical Industries

Sector: Healthcare

Followers

0
0
3
3
.
0
0
1
1
8
8
,
1
1
5.40 (0.30%)

As on 27 Nov, 2025 | 15:59

Open Trading A/c
Day Range
1,802.10
1,814.90
LH
52 Week Range
1,548.00
1,910.00
LH
Volume
* i
Bid / Ask
2,902,053.00
0.00 / 0.00

Sun Pharmaceutical Industries Announcements

Press Release

26 Nov, 2025 | 10:29am • Source: BSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 26, 2025

26 Nov, 2025 | 09:39am • Source: NSE

AstraZeneca Pharma India and Sun Pharma partner to help patients living with Hyperaklaemia in India

17 Nov, 2025 | 04:05pm • Source: BSE

Press Releases

12 Nov, 2025 | 04:04pm • Source: BSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Philogen provides update on Fibromun clinical study developments

12 Nov, 2025 | 09:28am • Source: NSE

Press Release

12 Nov, 2025 | 08:58am • Source: BSE

Q2 FY26 Earnings Call Transcript

11 Nov, 2025 | 04:00pm • Source: BSE

Intimation of Schedule of Analyst/Institutional Investor Meeting

10 Nov, 2025 | 05:04pm • Source: BSE

Intimation of Schedule of Analyst/Institutional Investor Meeting

07 Nov, 2025 | 07:47pm • Source: BSE

Newspaper Publication

06 Nov, 2025 | 12:01pm • Source: BSE

Investor Call Audio Recording

05 Nov, 2025 | 08:30pm • Source: BSE

Board has approved the proposal for alteration of the Memorandum of Association

05 Nov, 2025 | 04:21pm • Source: BSE

Financial Results for the quarter and half-year ended 30 September 2025

05 Nov, 2025 | 04:05pm • Source: BSE

Newspaper Advertisements

31 Oct, 2025 | 06:27pm • Source: BSE

Earnings call for the financial results of the second quarter on 05 November 2025

15 Oct, 2025 | 02:25pm • Source: BSE

Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider...

14 Oct, 2025 | 05:51pm • Source: BSE

ESG Overview for FY 2024-25

14 Oct, 2025 | 04:48pm • Source: BSE

NCLT approves the Composite Scheme of Arrangement.

08 Oct, 2025 | 08:23pm • Source: BSE

Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

07 Oct, 2025 | 02:39pm • Source: BSE

Newspaper Advertisements for 100 Days Campaign - Saksham Niveshak

24 Sep, 2025 | 06:01pm • Source: BSE